arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

CARDINAL HEALTH INC

CAH
$221.33 ▼ -0.70 (-0.32%) at close
Healthcare ·Wholesale-Drugs, Proprietaries & Druggists' Sundries ·USWholesale-Drugs, Proprietaries & Druggists' Sundries
72 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
41
Health
Weak
Bearish
auto_awesome

Analytical Summary

CARDINAL HEALTH INC faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth None
Op. Margin None
ROIC None
FCF / Share None
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

72-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$65.63B
↑ +18.8%
Net Income Profit after all expenses
$467.00M
↑ +16.8%
Operating Margin Operating profit as % of sales
1.1%
↑ +3.2% 29th
FCF / Share Free cash flow per share
$2.35
↓ -35.3%
Long-Term Debt Long-term obligations
$2.48B
↓ -7.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
28
Returns
10
Financial Health
71
Cash Quality
88

Dividend History

Dividend / share · sourced from SEC filings
$2.04 Latest / share
+1.0% YoY
+3.7% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 19 years · 72 quarters